|
rdfs:label
|
"5-aminosalikilata acido"@eo
"Mesalazin"@de
"Mesalazin"@hr
"Mesalazin"@id
"Mesalazin"@sh
"Mesalazin"@sr
"Mesalazin"@sv
"Mesalazin"@tr
"acide 5-aminosalicylique"@fr
"aminossalicilato"@pt
"mesalasin"@cy
"mesalatsiini"@fi
"mesalazin"@nn
"mesalazin"@sl
"mesalazina"@ca
"mesalazina"@es
"mesalazina"@it
"mesalazine"@en
"mesalazine"@nl
"mesalazine"@vi
"mesalazină"@ro
"mesalazyna"@pl
"Месалазин"@mk
"месалазин"@ru
"месалазин"@uk
"Մեսալազին"@hy
"מסלזין"@he
"مسالازین"@azb
"مسالازین"@fa
"ميسالازين"@ar
"ମେସାଲାଜିନ"@or
"メサラジン"@ja
"美沙拉嗪"@zh
"메살라진"@ko
|
|
skos:altLabel
|
"3-carboxy-4-hydroxyaniline"@cy
"3-carboxy-4-hydroxyaniline"@en
"5- ASA"@en
"5-ASA"@en
"5-ASA"@ca
"5-ASA"@cy
"5-ASA"@de
"5-ASA"@es
"5-ASA"@ko
"5-ASA"@nl
"5-ASA"@pl
"5-ASA"@ro
"5-Aminosalicylate"@en
"5-Aminosalicylate"@cy
"5-Aminosalicylsäure"@de
"5-aminosalicylic acid"@en
"5-aminosalicylic acid"@cy
"5-aminosalicylzuur"@nl
"5-アミノサリチル酸"@ja
"5-아미노살리실산"@ko
"89-57-6"@fr
"Aminosalicilato"@pt
"Aminosalicylsäure"@de
"Aminosalizylsäure"@en
"Apriso"@fr
"Asacol"@de
"Asacol"@fr
"Asacol"@nl
"C7H7NO3"@it
"Claversal"@de
"Ipocal"@fr
"Lialda"@fr
"Lialda"@de
"Mesacol"@fr
"Mesalamine"@de
"Mesalamine"@en
"Mesalamine"@nl
"Mesalazina"@en
"Mesalazine"@en
"Mesalazine"@cy
"Mesalazine"@fr
"Mesalazine"@he
"Mesalazinum"@en
"Mezavant"@de
"Mésalazine"@en
"Mésalazine"@fr
"Olsalazin"@de
"Pentasa"@de
"Pentasa"@fr
"Pentasa"@nl
"Pentasa®"@cy
"Pentasa®"@en
"Rowasa"@fr
"Salofalk"@de
"Salofalk"@fr
"Salofalk"@nl
"acid 5-aminosalicilic"@ro
"kwas 5-aminosalicylowy"@pl
"m-Aminosalicylic acid"@cy
"m-Aminosalicylic acid"@en
"mesalamina"@ca
"mesalamina"@pl
"p-Aminosalicylsaeure"@en
"Ácido 5-aminossalicílico"@pt
"Ácido aminossalicílico"@pt
"àcid 5-aminosalicílic"@ca
"Кансалазин"@ru
"Салазопиридазин"@ru
"מסלאזין"@he
"מסלאמין"@he
"بنتاسا"@ar
"مسالامین"@fa
"アサコール"@ja
"メサラミン"@ja
"메살라민"@ko
|
|
schema:description
|
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"хемиско соединение"@mk
"химическое соединение"@ru
"хімічна сполука"@uk
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଇନଫ୍ଲାମେଟୋରି ବାୱେଲ ଡିଜିଜ ରୋଗମାନଙ୍କରେ ଦିଆଯାଏ ।"@or
"രാസസംയുക്തം"@ml
"염증성 장질환 치료에 사용되는 항염증제"@ko
|
|
schema:dateModified
|
"2026-11-09T16:44:08+00:00"^^xsd:dateTime
|
|
schema:version
|
2567204115
|
|
wikibase:identifiers
|
51
|
|
wikibase:sitelinks
|
33
|
|
wikibase:statements
|
81
|
|
p:P10245
|
wd:statement/Q412479-246bd493-479a-d015-dbe7-a1155ba6da33
|
|
wd:statement/Q412479-c7b87236-4d13-67e8-a9ca-3f64129a7f59
|
|
p:P10283
|
wd:statement/Q412479-B3FC052B-8525-4D8A-8503-1FBABF9B310C
|
|
p:P11089
|
wd:statement/Q412479-63E03B88-B9DE-4837-9147-2906DE15454D
|
|
p:P11143
|
wd:statement/Q412479-BF40DBB4-BD5C-462E-A7B6-1D6C4F33F6DD
|
|
p:P11198
|
wd:statement/Q412479-4C1B16CA-5B27-4A20-94A2-6D533C6F7C52
|
|
p:P11199
|
wd:statement/Q412479-B41225D2-45D0-44D8-B697-C71663A9549E
|
|
p:P117
|
wd:statement/Q412479-0D4993C8-C472-4C76-9F14-01111A3FEFC3
|
|
p:P11931
|
wd:statement/Q412479-9bfa08e8-befe-4b49-ac63-9a31f68a2fe1
|
|
p:P129
|
wd:statement/Q412479-8565C4E3-3DAB-44AE-B6E4-F08B54598812
|
|
p:P1579
|
wd:statement/Q412479-9E33156E-F0AB-4738-90A9-95726F58D5EF
|
|
p:P18
|
wd:statement/Q412479-ab26b795-4e84-0561-e7ab-49cd75f204b7
|
|
wd:statement/Q412479-d0492d09-4fac-de36-d329-994094726db0
|
|
p:P2057
|
wd:statement/Q412479-25FC5D89-170E-4963-96B5-311E3EFFCA9C
|
|
p:P2062
|
wd:statement/Q412479-8C03EAE2-C8B1-4EC7-92CF-01BBA59469FB
|
|
p:P2067
|
wd:statement/Q412479-1A33728E-C18C-42C0-A23F-3320C55132B2
|
|
p:P2115
|
wd:statement/Q412479-FF1193E4-5C9E-4444-9A59-B2146DB82382
|
|
p:P2175
|
wd:statement/Q412479-2562E4BB-187A-4FEC-9E40-43419B6417C8
|
|
wd:statement/Q412479-2F1193F3-B8F4-44C3-9912-037C75692295
|
|
wd:statement/Q412479-C69E198A-4C9A-498D-8A68-E9B5A092DB9B
|
|
wd:statement/Q412479-CB135B38-3E39-445F-AE17-464820626460
|
|
wd:statement/Q412479-D36FAFF5-3FA5-43E6-B5CE-0E3521106631
|
|
wd:statement/Q412479-F60CA382-BD69-4B5F-ACBC-EC51060AB1AD
|
|
wd:statement/Q412479-FB767965-4A21-4E98-9EF0-A5F724C5E3AE
|
|
p:P2275
|
wd:statement/Q412479-20A659BC-E801-415B-A77C-9D42B35955C9
|
|
p:P231
|
wd:statement/Q412479-03C84A07-85CD-497C-B249-518D23E29DD0
|
|
p:P232
|
wd:statement/Q412479-39EA1F0C-9DBD-4A25-8D67-93E82AFA8C78
|
|
p:P233
|
wd:statement/Q412479-14AD00F4-82FC-47E5-9D18-EBB939FBA23D
|
|
p:P234
|
wd:statement/Q412479-A70E040B-D152-4FE3-B2CB-734BCE874B77
|
|
p:P235
|
wd:statement/Q412479-7404672D-7E59-4125-8CC3-FF5902EF99BA
|
|
p:P2566
|
wd:statement/Q412479-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q412479-0FCAB97D-E1A4-4926-B6F2-8426393673E0
|
|
p:P274
|
wd:statement/Q412479-F80D162A-019B-4966-A2B4-538992941E8A
|
|
p:P279
|
wd:statement/Q412479-9594928D-81E8-4DEF-95A8-2F84009FB2CB
|
|
p:P2840
|
wd:statement/Q412479-7FC6C08D-9842-491B-A818-1A00EAE1E915
|
|
wd:statement/Q412479-99FAC60A-1AE1-4584-877B-DBBEA1AC0B74
|
|
p:P2868
|
wd:statement/Q412479-42B7BCA9-A8BC-40D0-99E7-4C899A6C1003
|
|
wd:statement/Q412479-59C39803-98F4-4A60-8910-75F3DFD5D808
|
|
wd:statement/Q412479-9EFDF36D-C517-4EAB-8ABD-028E7AE89179
|
|
p:P2877
|
wd:statement/Q412479-F1364DC8-AF0A-4FD8-9336-A2D654E2B869
|
|
p:P2892
|
wd:statement/Q412479-B2E83C84-6954-4F18-9C7F-85B5705880C2
|
|
p:P31
|
wd:statement/Q412479-06D76BCC-F205-4C14-A475-2979D744F8F5
|
|
p:P3117
|
wd:statement/Q412479-39E5EB80-4244-470B-8B49-69073A8D828F
|
|
p:P3345
|
wd:statement/Q412479-3F6ACA4E-B78D-408F-815F-C5397E41FDAB
|
|
p:P3489
|
wd:statement/Q412479-E36D4856-0FC5-400E-A204-96DE2829863B
|
|
p:P3636
|
wd:statement/Q412479-1A7309DD-0FDB-4CAA-BAB6-5234988AEF84
|
|
p:P366
|
wd:statement/Q412479-DF49BA8A-082D-41BC-A166-18B1D67B2A0C
|
|
p:P373
|
wd:statement/Q412479-2a75b712-54c1-43b1-8db0-4508f0d28ddd
|
|
p:P3780
|
wd:statement/Q412479-60A0ABC8-1178-4B2E-BCD3-81AF3127A20B
|
|
wd:statement/Q412479-7A7614EB-A9F7-4655-89E8-2EB7DD395FB5
|
|
wd:statement/Q412479-82BE2A23-83FF-45C6-BE6F-9C859EFEFCC0
|
|
wd:statement/Q412479-A3D0FBBF-771E-492C-90C2-1B78651816CD
|
|
wd:statement/Q412479-D9FFBB2E-42F0-45AF-B1FD-166DE98E68B5
|
|
wd:statement/Q412479-EBD92113-79FE-4520-A990-C4486F015DEB
|
|
wd:statement/Q412479-F97BADCF-19B3-403F-8CA1-EE7CCD0C101E
|
|
p:P4168
|
wd:statement/Q412479-82DF1756-A638-4EB0-8724-43183D1B24F7
|
|
p:P486
|
wd:statement/Q412479-63E88C28-F9F4-4175-AF41-B10DAA98EBA5
|
|
p:P4964
|
wd:statement/Q412479-854F2EC6-7F90-4405-BC32-EBFE0B060FF1
|
|
p:P592
|
wd:statement/Q412479-C0C3188E-AD1D-405F-B65D-504241239357
|
|
p:P595
|
wd:statement/Q412479-04490CFF-3545-451F-8BC4-5BA3E0972D1D
|
|
p:P6366
|
wd:statement/Q412479-AF6B2674-F02A-4D31-A41D-E705CFB0FC3E
|
|
p:P646
|
wd:statement/Q412479-47ADB1AA-7FBD-45EB-A231-A22D0AE176DB
|
|
p:P652
|
wd:statement/Q412479-880EC493-C754-4374-B39F-5C9AA25A3D16
|
|
p:P661
|
wd:statement/Q412479-980437E5-E16C-4FDB-B410-43547FBE9E60
|
|
p:P662
|
wd:statement/Q412479-32F599C9-5B74-46F9-8C87-BCDB0DFD812D
|
|
p:P665
|
wd:statement/Q412479-B7BD5EA0-952E-4C55-8FA2-43F6BC788DFD
|
|
p:P6689
|
wd:statement/Q412479-A1413C39-9805-4B65-ABD4-18E590A820A2
|
|
p:P672
|
wd:statement/Q412479-0084e70b-4f52-8c7e-c57b-456cfe5bcaf6
|
|
wd:statement/Q412479-48147eff-479a-f3ab-913a-18274febef74
|
|
wd:statement/Q412479-4daf09f5-49b0-6b5a-81f9-a0d76f070b5a
|
|
wd:statement/Q412479-5f36de32-4083-cb66-f4d9-4d5dc3e75a82
|
|
wd:statement/Q412479-8d9d1156-4865-de1b-068b-522e3bffc398
|
|
wd:statement/Q412479-bdf7cd9d-472b-8662-f5d3-e1fce8415f90
|
|
p:P679
|
wd:statement/Q412479-4298D3EA-E94C-4107-8741-681B87441BCE
|
|
p:P683
|
wd:statement/Q412479-8188BF61-32D4-4B24-8761-FF97D6AC2FCE
|
|
p:P715
|
wd:statement/Q412479-183E1FD3-65E8-469F-9A90-1F1594DCCF3C
|
|
p:P7830
|
wd:statement/Q412479-E3F5389F-40D7-4F36-A2C4-D0E18B8B5D0B
|
|
p:P8121
|
wd:statement/Q412479-84E5DCB7-CAA0-43FC-83F6-2BA86213D285
|
|
p:P8494
|
wd:statement/Q412479-857A2AD2-26F6-4F6F-AEB7-B79A108C26BC
|
|
p:P9405
|
wd:statement/Q412479-38E1EF22-C333-41A1-96D2-952A0C3F25B9
|
|
p:P9635
|
wd:statement/Q412479-EEED8E9F-4AB9-4150-A4CD-A536968AFCC1
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000147614>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D019804>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL704>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2779174533>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/3933>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D00377>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.241.223.100.050.300.500>
|
|
<http://id.nlm.nih.gov/mesh/D02.241.223.100.300.595.100.540>
|
|
<http://id.nlm.nih.gov/mesh/D02.241.511.390.595.100.540>
|
|
<http://id.nlm.nih.gov/mesh/D02.455.426.559.389.127.020.452.750>
|
|
<http://id.nlm.nih.gov/mesh/D02.455.426.559.389.127.281.595.100.540>
|
|
<http://id.nlm.nih.gov/mesh/D02.455.426.559.389.657.410.595.100.540>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_6775>
|
|
wdt:P10245
|
"a614021"
|
|
"a688021"
|
|
wdt:P10283
|
"C2779174533"
|
|
wdt:P11089
|
"513359"
|
|
wdt:P11143
|
"Mesalazine"
|
|
wdt:P11198
|
"1710"
|
|
wdt:P11199
|
"PD000235"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/5-amino-2-hydroxybenzoic%20acid%20200.svg>
|
|
wdt:P11931
|
"19803"
|
|
wdt:P129
|
Peroxisome proliferator activated receptor gamma
|
|
wdt:P1579
|
"2090421"
|
|
wdt:P18
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Mesalazine%203D.png>
|
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Mesalazine%20structure.svg>
|
|
wdt:P2057
|
"HMDB0014389"
|
|
wdt:P2062
|
"7512"
|
|
wdt:P2067
|
153.042593^^xsd:decimal
|
|
wdt:P2115
|
"N0000147614"
|
|
wdt:P2175
|
ulcerative colitis
|
|
sigmoid disease
|
|
microscopic colitis
|
|
colitis
|
|
irritable bowel syndrome
|
|
proctitis
|
|
wdt:P2275
|
"mesalazine"@en
|
|
wdt:P231
|
"89-57-6"
|
|
wdt:P232
|
"201-919-1"
|
|
wdt:P233
|
"C1=CC(=C(C=C1N)C(=O)O)O"
|
|
wdt:P234
|
"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)"
|
|
wdt:P235
|
"KBOPZPXVLCULAV-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.001.745"
|
|
wdt:P267
|
"A07EC02"
|
|
wdt:P274
|
"C₇H₇NO₃"
|
|
wdt:P279
|
aminosalicylic acids
|
|
wdt:P2840
|
"38877"
|
|
"759301"
|
|
wdt:P2868
|
5-lipoxygenase inhibitor
|
|
non-steroidal anti-inflammatory drug
|
|
cyclooxygenase inhibitors
|
|
wdt:P2877
|
"31297"
|
|
wdt:P2892
|
"C0127615"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID5024506"
|
|
wdt:P3345
|
"52582"
|
|
wdt:P3489
|
US pregnancy category B
|
|
wdt:P3636
|
"OO3"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Mesalazine"
|
|
wdt:P3780
|
Apriso
|
|
Asacol
|
|
Canasa
|
|
Delzicol
|
|
Lialda
|
|
Pentasa
|
|
Rowasa
|
|
wdt:P4168
|
"613406"
|
|
wdt:P486
|
"D019804"
|
|
wdt:P4964
|
"splash10-0f79-0900000000-db75ae2d436dd6156c91"
|
|
wdt:P592
|
"CHEMBL704"
|
|
wdt:P595
|
"2700"
|
|
wdt:P6366
|
"2779174533"
|
|
wdt:P646
|
"/m/046yrb"
|
|
wdt:P652
|
"4Q81I59GXC"
|
|
wdt:P661
|
"3933"
|
|
wdt:P662
|
"4075"
|
|
wdt:P665
|
"D00377"
|
|
wdt:P6689
|
"SM862104"
|
|
wdt:P672
|
"D02.241.223.100.050.300.500"
|
|
"D02.241.223.100.300.595.100.540"
|
|
"D02.241.511.390.595.100.540"
|
|
"D02.455.426.559.389.127.020.452.750"
|
|
"D02.455.426.559.389.127.281.595.100.540"
|
|
"D02.455.426.559.389.657.410.595.100.540"
|
|
wdt:P679
|
"21840"
|
|
wdt:P683
|
"6775"
|
|
wdt:P715
|
"DB00244"
|
|
wdt:P7830
|
"Mesalamine"
|
|
wdt:P8121
|
"c0732"
|
|
wdt:P8494
|
"DTXCID804506"
|
|
wdt:P9405
|
"20037775"
|
|
wdt:P9635
|
"547"
|